Literature DB >> 20929352

Measles in the United States during the postelimination era.

Amy Parker Fiebelkorn1, Susan B Redd, Kathleen Gallagher, Paul A Rota, Jennifer Rota, William Bellini, Jane Seward.   

Abstract

BACKGROUND: Measles affected entire birth cohorts in the prevaccine era but was declared eliminated in the United States in 2000 because of a successful measles vaccination program.
METHODS: We reviewed US surveillance data on confirmed measles cases reported to the Centers for Disease Control and Prevention and data on national measles-mumps-rubella (MMR) vaccination coverage during postelimination years 2001-2008.
RESULTS: During 2001-2008, a total of 557 confirmed cases of measles (annual median no. of cases, 56) and 38 outbreaks (annual median no. of outbreaks, 4) were reported in the United States; 232 (42%) of the cases were imported from 44 countries, including European countries. Among case-patients who were US residents, the highest incidences of measles were among infants 6-11 months of age and children 12-15 months of age (3.5 and 2.6 cases/1 million person-years, respectively). From 2001 through 2008, national 1-dose MMR vaccine coverage among children 19-35 months of age ranged from 91% to 93%. From 2001 through 2008, a total of 285 US-resident case-patients (65%) were considered to have preventable measles (ie, the patients were eligible for vaccination but unvaccinated). During 2004-2008, a total of 68% of vaccine-eligible US-resident case-patients claimed exemptions for personal beliefs.
CONCLUSIONS: The United States maintained measles elimination from 2001 through 2008 because of sustained high vaccination coverage. Challenges to maintaining elimination include large outbreaks of measles in highly traveled developed countries, frequent international travel, and clusters of US residents who remain unvaccinated because of personal belief exemptions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20929352     DOI: 10.1086/656914

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  A longitudinal analysis of the effect of nonmedical exemption law and vaccine uptake on vaccine-targeted disease rates.

Authors:  Y Tony Yang; Vicky Debold
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

Review 2.  Epidemiology of vaccine hesitancy in the United States.

Authors:  Mariam Siddiqui; Daniel A Salmon; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2013-11-18       Impact factor: 3.452

3.  Does the relative importance of MMR vaccine concerns differ by degree of parental vaccine hesitancy?: An exploratory study.

Authors:  Charitha Gowda; Sarah E Schaffer; Kristin Kopec; Arielle Markel; Amanda F Dempsey
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

4.  Protecting the public's health: critical functions of the Section 317 Immunization Program-a report of the National Vaccine Advisory Committee.

Authors: 
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

Review 5.  Nonmedical exemptions from school immunization requirements: a systematic review.

Authors:  Eileen Wang; Jessica Clymer; Cecilia Davis-Hayes; Alison Buttenheim
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

Review 6.  Vaccination in HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2014-07-16       Impact factor: 5.078

7.  Identifying postelimination trends for the introduction and transmissibility of measles in the United States.

Authors:  Seth Blumberg; Wayne T A Enanoria; James O Lloyd-Smith; Thomas M Lietman; Travis C Porco
Journal:  Am J Epidemiol       Date:  2014-04-30       Impact factor: 4.897

8.  Reduced immunity to measles in adults with major depressive disorder.

Authors:  Bart N Ford; Robert H Yolken; Faith B Dickerson; T Kent Teague; Michael R Irwin; Martin P Paulus; Jonathan Savitz
Journal:  Psychol Med       Date:  2018-03-19       Impact factor: 7.723

Review 9.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Children and Adolescents Unvaccinated Against Measles: Geographic Clustering, Parents' Beliefs, and Missed Opportunities.

Authors:  Philip J Smith; Edgar K Marcuse; Jane F Seward; Zhen Zhao; Walter A Orenstein
Journal:  Public Health Rep       Date:  2015 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.